تحميل...
Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
Type II endometrial carcinomas (ECs) are responsible for most endometrial cancer-related deaths due to their aggressive nature, late stage detection and high tolerance for standard therapies. However, there are no targeted therapies for type II ECs, and they are still treated the same way as the cli...
محفوظ في:
| الحاوية / القاعدة: | Int J Mol Sci |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
MDPI
2018
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6121653/ https://ncbi.nlm.nih.gov/pubmed/30104481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19082380 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|